dots

Brain Laboratory
Assistance from the distance

Brain Laboratory provides informational assistance to research groups and biotech startup companies with focused research on neurodegenerative diseases.

About us

Every research and drug development starts with revision of peer-reviewed published data. It takes months to gather information on a single specific topic. We supply our partners with databases of experimental and clinical results on neurodegenerative diseases, thus speeding up the process of developing novel diagnostic tools and drug discovery. We also offer information on the “New Age” healing technology systems as: Med Beds, laser therapy and unique quantum technology devices that are also directly linked with the cause of curing degenerative diseases.

Shield

Safety

Your tokens are kept in safe on Stellar DEX (Lobstr, Scopuly, Stellarterm, Stellarport).

Shield

Positive mind therapy

We believe that positive mind is the best medicine. It is a part of self-acceptance and self-love. Help the people avoid unequal struggle in society.

Shield

Charity driven initiatives

A contribution wallet for financing research and promoting healthy brain worldwide will be sponsored by 0.5 percent of the total Brain Laboratory coins venue.

Shield

Flexible Computing

Flexible, efficient and scalable computing infrastructure for increased processing power.

Shield

Smart Contracts

Our team uses smart contracts to ensure that each transaction on this DEX platform is accurate and legitimate.

Shield

Cheap Transactions

Brain Laboratory tokens eliminates any need for middlemen, enabling cheaper transactions.

Why choose us?

Over 65 million people worldwide are suffering from incurable neurodegenerative diseases such as Alzheimer’s Disease (AD), Parkinson’s Disease (PD), Huntington’s Disease (HD), Multiple Sclerosis (MS), Amyotrophic lateral sclerosis (ALS), etc. Unfortunately, the cause of these diseases is not completely understood, therefore there is still no cure to counteract or stop disease evolution. Big pharmaceutical companies, research groups and biotech companies are rushing to find a cure and therefore save lives of millions. New research data is published every day supplying fresh knowledge, thus aiding in revealing the pathophysiology and source of the diseases. It is very complex to grasp and gather all the new information. We use Machine Learning (ML) for data acquisition and database update on various neurodegenerative diseases. The collected big data serves as a solid basement for treatment development and improvement used by research groups and biotech startup companies.

Total supply


5,000,000


Symbol


NST


Token Name


Neuro Sense Token


Neuro Sense Token

There are 86 Billion neurons in your brain which send and receive information. Neurons are interconnected through synapses, through which the processed information is transmitted. The neurons communicate using electric signals. We can record electrical signals in the brain by placing electrodes near the neurons to quantify action potentials. There are neurons in the brain that carry information about everything we see, feel, touch, or think. We are developing a robotic system for insertion into the brain, which can help in the transmission of the neural electric signals in case of damage or disease. The Neuro Sense Technology would work like a brain prosthetic to those in need. People suffering from hearing or loss, paralysis, seizures, etc. would compensate the disease with this novel technology.

Total supply


10,000,000


Symbol


NOVAX


Token Name


Anti Vaccine Token


Anti Vaccine Token

Anti Vaccine is a revolutionary token created to help the "Anti Vaccine" movement financially and morally. Vaccines are a really delicate topic these days. The freedom to choose to get vaccinated with the new underdeveloped anti-COVID vaccines should not be forced by the government. NOVAX has a vested interest in supporting the people's struggle against government vaccination laws. It's aimed at the propagation of freedom and also fighting against corruption in the government influenced by Big Pharma.

Total supply


10,000,000


Symbol


MBED


Token Name


Med Bed Token


Med Bed Token

A revolutionary technology, Medbeds Quantum Healing Technology, will be available to humanity sooner than anyone believed. As technology evolves at a cosmic speed, medical beds with unique features including diagnostic tools, surgical repair, cellular and DNA analysis, will be designed. Thus, health maintenance and healing can happen locally with the help of one single machine. BrainLaboratory company strongly believes that these medbeds will represent a quantum leap in the business of healthcare and will improve the quality of life all over the world. Help us invest resources in developing a tool for healing with no chemotherapy, toxic chemicals, radiation, organ removal, or having to live with scars or disfunction as a result of a degenerative disease such as Alzheimer's and Parkinson's diseases.

Total supply


5,000,000


Symbol


PDT


Token Name


Parkinson’s Token


Parkinson’s Disease Token

An estimated 7 to 10 million people worldwide have Parkinson’s disease. Someone is diagnosed with Parkinson’s every hour in the U.K. Most are 50 or older and rely on family, friends, or neighbors for assistance. The PDT earnings will help with the improvement of our Machine Learning engine as well as for charity foundations.

Total supply


5,000,000


Symbol


ADT


Token Name


Alzheimer’s Token


Alzheimer’s Disease Token

Yearly, there are approximately 10 million new cases of Alzheimer’s Disease. Dementia has significant social and economic implications in terms of direct medical and social care costs, and the cost of informal care. The ADT revenue will fund the establishment of hardware needed for database construction and the ML framework development.

Roadmap

1.Brain Laboratory creates it's first tokens and launches officially.

Racheta

2.The Machine Learning engine is developed and high end hardware is acquired.

Racheta

3.ADT & PDT tokens listed on Stellar DEX. Marketing and word spreading on social media platforms.

Racheta

4.Improvement of the machine learning framework. Increase of disease spectrum databases.

Racheta

5.Listing on other platforms.

Racheta

6.Staking

Racheta

7.Charity events and local fund raising.

Racheta

Partners

News

Landmark Alzheimer's drug approval confounds research community

Aducanumob - is the first approved drug that attempts to treat a possible cause of the neurodegenerative disease

Read More
Glia Brain Cells May Open Door to Treatment Strategy

Brain cells called glia work to protect the brain from damage in Huntington’s disease and may be used as a treatment

Read More
Scientists move closer to developing 'game-changing' test to diagnose Parkinson's

Scientists at The University of Manchester have developed a revolutionary technique to diagnose patients with PD

Read More
Smartphones may play a pivotal role in personalized treatment of PD patients.

Here we examine the performance and limitations of smartphones in collecting RWD in the remote mPower observational study of Parkinson’s disease (PD).

Read More
$5M Grant Supports Phase 1 Trial of AAV2-BDNF, Potential Gene Therapy

The therapy aims to deliver the gene to cells using an engineered adeno-associated virus (AAV2). This would prompt the cells to “read” the gene and produce the BDNF protein.

Read More
MedBeds will use novel DNA repair techniques for correction of replication errors.

Since human expansion into space will involve extended off-planet stays, exposure to ionizing space radiation is a major factor conditioning the success of future missions.

Read More
Study identifies how COVID-19 linked to Alzheimer's disease-like cognitive impairment

The findings indicate an overlap between COVID-19 and brain changes common in AD, and may help inform therapeutic strategies for associated cognitive impairment.

Read More
Epilepsy Medication Use Weighs on Patients’ Quality of Life, Study Finds

As the disease progresses, additional medications may need to address co-existing conditions related to PD, including non-motor symptoms.

Read More

Find us on media